Projects per year
Personal profile
Education
- 2000-2007 M.D., School of Medicine, National Cheng Kung University
Experience
- Director, Division of Hematology & Oncology, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
- Attending Physician, Division of Hematology & Oncology, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
- 2018.06- Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2010.08-2012.07 Chief Resident Physician, Linkou Chang Gung Memorial Hospital
- 2007.08-2010.07 Resident Physician, Linkou Chang Gung Memorial Hospital
Fingerprint
Dive into the research topics where Chia-Lun Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
雙打擊在瀰漫大B細胞淋巴瘤所扮演的角色-致病機轉與臨床特色之探討-MCL1蛋白在雙打擊瀰漫大B細胞淋巴瘤的表現及其臨床的角色
Chang, C.-L. (PI)
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
新聘教師研究補助
Chang, C.-L. (PI)
11/1/18 → 10/31/20
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
Acceptance of Virtual Reality Training for Chemotherapy Administration among Nursing Students
Chang, C. L., Tsai, S. C., Lu, C. Y., Chan, C. J., Huang, T. W. & Gautama, M. S. N., 2025, (Accepted/In press) In: CIN - Computers Informatics Nursing. 10.1097/CIN.0000000000001246.Research output: Contribution to journal › Article › peer-review
-
Comparative effectiveness of netupitant-palonosetron plus dexamethasone versus aprepitant-based regimens in mitigating chemotherapy-induced nausea and vomiting: a meta-analysis of randomized controlled trials
Luo, W.-T., Chang, C.-L., Huang, T.-W. & Gautama, M. S. N., Feb 6 2025, In: Oncologist.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Cumulative Dose of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Cohort Study
Kuo, Y. H., Kuo, C. N., Chang, C. L. & Ko, Y., Jul 2025, In: Journal of Gastroenterology and Hepatology (Australia). 40, 7, p. 1745-1753 9 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Effectiveness and Safety of Reduced and Standard Initial Doses of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study in Taiwan
Kuo, Y. H., Kuo, C. N., Chang, C. L. & Ko, Y., Nov 2025, In: Pharmacoepidemiology and Drug Safety. 34, 11, e70221.Research output: Contribution to journal › Article › peer-review
-
Effectiveness and Safety of Regorafenib and TAS-102 in Patients with Metastatic Colorectal Cancer: A Nationwide Population-Based Study in Taiwan
Chang, Y. W., Kuo, C. N., Chang, C. L., Hsu, J. C. & Ko, Y., Jul 2025, In: Cancer Research and Treatment. 57, 3, p. 830-839 10 p.Research output: Contribution to journal › Article › peer-review
Open Access